Requip XL tablets (extended-release ropinirole, fromGlaxoSmithKline) has been made available in a 12mg strength in addition to the 2mg,4mg, and 8mg strengths already available on the market.

Requip XL is indicated for the treatment of idiopathicParkinson’s disease.

For more information call (888) 825-5249 or visit www.REQUIPXL.com.